Publication:
Medication reconciliation service in hospitalized patients with infectious diseases during coronavirus disease-2019 pandemic: An observational study

Simple item page
dc.contributor.authorENVER, CÜNEYD
dc.contributor.authorERTÜRK ŞENGEL, BUKET
dc.contributor.authorSANCAR, MESUT
dc.contributor.authorKORTEN, VOLKAN
dc.contributor.authorOKUYAN, BETÜL
dc.contributor.authorsENVER C., ERTÜRK ŞENGEL B., SANCAR M., KORTEN V., OKUYAN B.
dc.date.accessioned2023-09-12T05:34:10Z
dc.date.available2023-09-12T05:34:10Z
dc.date.issued2023-08-01
dc.description.abstractObjectives: To determine the prevalence and type of medication discrepancies and factors associated with unintentional discrepancies and identify the rate of hospital readmission and emergency service visit within 30 days after discharge among hospitalized patients with infectious diseases and receiving clinical pharmacist-led medication reconciliation during the coronavirus disease-2019 (COVID-19) pandemic. Materials and Methods: This observational study was conducted in the internal medicine and infectious diseases wards of a tertiary university hospital between July 2020 and February 2021 among hospitalized adult patients with infectious diseases. Medication reconciliation service (including patient counseling) was provided in person or by telephone. The number and type of medication discrepancies detected during the medication reconciliation services, the acceptance rate of pharmacists’ recommendation, and factors associated with having at least one unintentional medication discrepancy at admission were evaluated. At follow-up, hospital readmission and emergency service visit within 30 days after discharge were assessed by telephone. Results: Among 146 patients, 84 (57.5%) had at least one unintentional discrepancy at admission. Only three unintentional discrepancies were determined in three patients at hospital discharge. All the pharmacists’ recommendations for medication discrepancies were accepted by the physicians. Having COVID-19 [odds ratio (OR): 2.25, 95% confidence interval (CI): 1.15-4.40; p<0.05], being at a high risk for medication error (OR: 2.01, 95% CI: 1.03-3.92; p<0.05), and higher number of medications used at home (OR: 1.41, 95% CI: 1.23-1.61; p<0.001) were associated with having at least one unintentional discrepancy at admission. The rates of 30 day hospital readmission and admission to the emergency medical service were 12.3% and 15.8%, respectively. Conclusion: Medication reconciliation service provided by in-person or by telephone was useful for detecting and solving unintentional medication discrepancies during the COVID-19 pandemic.
dc.identifier.citationENVER C., ERTÜRK ŞENGEL B., SANCAR M., KORTEN V., OKUYAN B., "Medication Reconciliation Service in Hospitalized Patients with Infectious Diseases During Coronavirus Disease-2019 Pandemic: An Observational Study", Turkish Journal of Pharmaceutical Sciences, cilt.20, sa.4, ss.210-217, 2023
dc.identifier.doi10.4274/tjps.galenos.2022.08455
dc.identifier.endpage217
dc.identifier.issn1304-530X
dc.identifier.issue4
dc.identifier.startpage210
dc.identifier.urihttps://avesis.marmara.edu.tr/api/publication/26a5263f-d57c-40da-b094-3acb27b81c83/file
dc.identifier.urihttps://hdl.handle.net/11424/293184
dc.identifier.volume20
dc.language.isoeng
dc.relation.ispartofTurkish Journal of Pharmaceutical Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectYaşam Bilimleri
dc.subjectBiyoteknoloji
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectMedicine
dc.subjectLife Sciences
dc.subjectBiotechnology
dc.subjectHealth Sciences
dc.subjectNatural Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectKlinik Tıp
dc.subjectMikrobiyoloji
dc.subjectTROPİKAL TIP
dc.subjectBİYOTEKNOLOJİ VE UYGULAMALI MİKROBİYOLOJİ
dc.subjectClinical Medicine (MED)
dc.subjectLife Sciences (LIFE)
dc.subjectCLINICAL MEDICINE
dc.subjectMICROBIOLOGY
dc.subjectTROPICAL MEDICINE
dc.subjectBIOTECHNOLOGY & APPLIED MICROBIOLOGY
dc.subjectMoleküler Tıp
dc.subjectFarmasötik bilim
dc.subjectMolecular Medicine
dc.subjectPharmaceutical Science
dc.subjectclinical pharmacist
dc.subjectCOVID-19
dc.subjectinfectious disease medicine
dc.subjectMedication reconciliation
dc.subjectunintentional discrepancy
dc.subjectMedication reconciliation
dc.subjectclinical pharmacist
dc.subjectinfectious disease medicine
dc.subjectCOVID-19
dc.subjectunintentional discrepancy
dc.titleMedication reconciliation service in hospitalized patients with infectious diseases during coronavirus disease-2019 pandemic: An observational study
dc.typearticle
dspace.entity.typePublication
local.avesis.id26a5263f-d57c-40da-b094-3acb27b81c83
local.indexed.atPUBMED
local.indexed.atSCOPUS
relation.isAuthorOfPublicationfb414cc8-20a1-4d7c-8c51-06b95dc3a551
relation.isAuthorOfPublication67d5b9df-08b7-4c37-b042-45ea89a4c23d
relation.isAuthorOfPublication87a6fc65-406c-478f-bc6d-ffaaaf1f7b31
relation.isAuthorOfPublication27f6afa3-0e46-45c9-a302-a6493c69bffb
relation.isAuthorOfPublicationf6e7969a-ea61-403f-8772-1a8478556223
relation.isAuthorOfPublication.latestForDiscoveryfb414cc8-20a1-4d7c-8c51-06b95dc3a551

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
11.pdf
Size:
525.31 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs